“The need for innovative mental health services has never been greater. Reid Robison, Chief Medical Officer and Director of Novamind. “Spravato™ requires specialized infrastructure and processes that can be difficult for small mental health practices to implement, but Cedar Psychiatry has the scale and expertise to effectively manage the challenges of offering these novel medications to our clients,” commented Dr. Clinical research studies that supported FDA approval showed that Spravato™ can effectively benefit people with these conditions, which can be difficult to treat. FDA for treatment-resistant depression (TRD) in March 2019, and for major depressive disorder (MDD) with suicidal ideation or behaviour in August 2020. Spravato™ is a version of ketamine that was approved by the U.S. During the same period, total Spravato™ treatments at Cedar Psychiatry clinics have grown over 400%. The number of ketamine treatments administered at Cedar Psychiatry clinics grew 90% from 2019 to 2020. Cedar Psychiatry specializes in evidence-based therapeutic protocols that facilitate the integration of ketamine experiences and optimize treatment outcomes for clients. Launched in 2016, Cedar Psychiatry is a leading provider of innovative, evidence-based mental health therapies in the United States.Ĭlients receiving ketamine treatment at Novamind’s Cedar Psychiatry clinics are offered specialized therapy, pre- and post-ketamine-administration (ketamine-assisted psychotherapy). TORONTO, ON /Janu/ Novamind Inc. (CSE:NM) (“Novamind”), a leading mental health company specialized in psychedelic medicine, is proud to announce significant milestones at its Cedar Psychiatry clinics: administering over 5,000 ketamine treatments and over 2,000 Spravato™ treatments. NEXT SUPER STOCK NexTech AR (OTC: NEXCF) “New AI Tech Unleashing Explosive Revenue Growth in 2023″□ ![]() Nextech AR (OTC: NEXCF) Announces Details of Generative AI IPO Spin-out Toggle3D Meta Platforms (NASDAQ: META) CEO Mark Zuckerberg: “Our Goal is to be Leader in Generative AI”ĪI/ML Innovations (OTC: AIMLF) Tech2Heal Wins Prestigious Innovation Grand Prize Award Palantir (NYSE: PLTR) Signs $50 Million Expansion with SOMPO Holdings Nextech AR (OTC: NEXCF) Achieves Major Generative AI Breakthrough in 3D Model Texture Creation Nextech AR (OTC: NEXCF) Lands Major Enterprise 3D Model Deal With S&P 500 Company Top 10 RetailerĬ3 AI (NYSE: AI) Provides Mission-Critical AI Solutions for the United States Air Force Crowd-Sourced Flight Data ProgramĬ3 AI (NYSE: AI) Announces Launch of C3 Generative AI Product Suite ![]() Nextech AR’s (OTC: NEXCF) AI-Powered 3D Design Studio Toggle3D Launches Major Tech Upgrade
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |